TrialEuropean journal of heart failure2018

Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial.

Phillip H Lam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.